Fig. 1

Alterations of the immune response during the progression of premalignant lesions to colorectal cancer (a) The alterations of tumor-infiltrating lymphocytes (TILs) in P-values (left panel) and predicted fraction (right panel) (b) The alterations of immune cell-type-specific genes for P-values (left panel) and expression levels (right panel).